Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 29, 2026
[Hematologic responses with favorable safety in three elderly patients with polycythemia vera treated with ropeginterferon alfa-2b]
Satoko Oka, Yuina Ueda, Takaya Mitsuyoshi, et al.
Internal Medicine (Tokyo, Japan)
|
October 29, 2025
Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
Leukemia & Lymphoma
|
December 25, 2025
Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 9, 2018
[Autologous peripheral blood stem cell transplantation for treating primary central nervous system lymphoma: a single-center retrospective study]
Yukiko Okubo, Hitomi Kaneko, Takuya Shimizu, et al.
Cell Reports. Medicine
|
January 24, 2026
CAR-T cells with the CD38<sup>-</sup>CD73<sup>-</sup>Tim-3<sup>-</sup>HLA-DR<sup>+</sup> phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL
Takashi Mikami, Itaru Kato, Mara Anais Llamas-Covarrubias, et al.
Blood Advances
|
May 17, 2022
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
Makiko Yamasaki-Morita, Yasuyuki Arai, Takashi Ishihara, et al.
Ejhaem
|
January 27, 2025
HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML
Takaya Mitsuyoshi, Yasuyuki Arai, Tadakazu Kondo, et al.
Blood Advances
|
July 14, 2020
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT
Hiroyuki Matsui, Yasuyuki Arai, Hiroharu Imoto, et al.
Transplantation and Cellular Therapy
|
July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry
Junya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 29, 2026
[Hematologic responses with favorable safety in three elderly patients with polycythemia vera treated with ropeginterferon alfa-2b]
Satoko Oka, Yuina Ueda, Takaya Mitsuyoshi, et al.
Internal Medicine (Tokyo, Japan)
|
October 29, 2025
Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
Leukemia & Lymphoma
|
December 25, 2025
Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 9, 2018
[Autologous peripheral blood stem cell transplantation for treating primary central nervous system lymphoma: a single-center retrospective study]
Yukiko Okubo, Hitomi Kaneko, Takuya Shimizu, et al.
Cell Reports. Medicine
|
January 24, 2026
CAR-T cells with the CD38<sup>-</sup>CD73<sup>-</sup>Tim-3<sup>-</sup>HLA-DR<sup>+</sup> phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL
Takashi Mikami, Itaru Kato, Mara Anais Llamas-Covarrubias, et al.
Blood Advances
|
May 17, 2022
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
Makiko Yamasaki-Morita, Yasuyuki Arai, Takashi Ishihara, et al.
Ejhaem
|
January 27, 2025
HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML
Takaya Mitsuyoshi, Yasuyuki Arai, Tadakazu Kondo, et al.
Blood Advances
|
July 14, 2020
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT
Hiroyuki Matsui, Yasuyuki Arai, Hiroharu Imoto, et al.
Transplantation and Cellular Therapy
|
July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry
Junya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Page
of 1